Navigation Links
Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
Date:9/10/2009

onths. Patients were also allowed to remain on all other stable CF therapies during the study.

"The results of this study are very gratifying, particularly given the heavily treated nature of the patients included in this trial," stated Dr. Jeff Loutit, Chief Medical Officer of Mpex Pharmaceuticals. "It is difficult for new agents to show benefit on top of state-of-the-art care in CF, and generating statistically significant results across a broad range of key endpoints in this Phase 2b study bodes well for success in Phase 3."

"We thank the participating CF patients and physicians for helping make this trial a success," stated Daniel Burgess, President and CEO of Mpex Pharmaceuticals. "We are eager to meet with CF experts and regulatory authorities in the U.S. and Europe to discuss these results and determine the most expeditious path to move Aeroquin through Phase 3 development."

Patients with CF suffer from chronic infections of the lower respiratory tract that can be caused by multiple bacteria, including P. aeruginosa. Chronic pulmonary infection is associated with a decrease in lung function over time caused by inflammation arising from bacteria and their toxins. Periodic exacerbations in the lung result from bacterial overgrowth, and these exacerbations are implicated as a major cause of morbidity and mortality in CF patients.

About Aeroquin (MP-376)

MP-376 is a proprietary formulation of levofloxacin that has been optimized for aerosol delivery using a customized Investigational eFlow(R) Nebulizer System (PARI Pharma GmbH). Levofloxacin is a fluoroquinolone antibiotic that has been widely used in a variety of indications for over a decade and has established safety and efficacy when administered orally or intravenously against many bacterial pathogens, including P. aeruginosa. Administration of MP-376 with a high efficiency nebulizer to th
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
2. Rib-X Pharmaceuticals to Present at the 49th ICAAC
3. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009
4. Dont Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
5. EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer
6. Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog
7. Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet
8. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
11. Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Aug. 26, 2014 Trovagene, Inc. (NASDAQ: ... Dx Summit; Moving Assays to the Clinic ... Monitoring of Cell Free Tumor DNA in Urine." ... of its Precision Cancer Monitoring (PCM) platform and ... for the detection of tumor DNA mutations from ...
(Date:8/26/2014)... Aug. 26, 2014  That,s Nice LLC, a research-focused ... announced the formation of a new dedicated team that ... expanded team will combine current and new staff in ... Nice. Guy Tiene has ... the team. Tiene was previously Director of Marketing for ...
(Date:8/26/2014)... Boston, MA (PRWEB) August 26, 2014 ... to manage core research facilities , the ... of Kansas Cancer Center have chosen iLab Solutions' ... and effectively increase productivity. , "We are ... Center and KU Cancer Center signed on with ...
(Date:8/26/2014)... , Aug. 26, 2014 /PRNewswire-iReach/ -- The crowdfunding ... is in full effect on the popular crowdfunding platform ... their support for the biofeedback belt. The $75,000 funding ... mass-produce and distribute the product. Photo - ... small device worn on the lower back that silently ...
Breaking Biology Technology:Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3The University of Kansas Medical Center and The University of Kansas Cancer Center Select iLab Solutions Web-based Software to Streamline Operations 2The University of Kansas Medical Center and The University of Kansas Cancer Center Select iLab Solutions Web-based Software to Streamline Operations 3PosturePulse, A Biofeedback Posture-Improving Belt, Improves Posture While Sitting or Standing 2
... DIEGO -- In the Sept 9, 2010 issue of ... of concept studies that show its proprietary compound, NGP ... Alzheimer,s disease (AD) in a transgenic mouse model. ... the gamma secretase modulator (GSM) compound from NGP, the ...
... GAITHERSBURG, Md. Using a one-of-a-kind instrument designed and ... (NIST), an international team of researchers have "unveiled" a ... in graphene can split up into an unexpected and ... low temperatures and extremely high magnetic fields. Published in ...
... THE WOODLANDS, Texas, Sept. 9 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... president and chief executive officer, will present at the ... 16, 2010 at 9:10 a.m. Eastern Time. ...
Cached Biology Technology:Neurogenetic studies show proprietary compound reduces brain plaques linked to Alzheimer's 2NIST researchers hear puzzling new physics from graphene quartet's quantum harmonies 2NIST researchers hear puzzling new physics from graphene quartet's quantum harmonies 3Lexicon to Present at Stifel Nicolaus Healthcare Conference 2
(Date:8/26/2014)... colony of harmful bacteria, biofilms make the treatment ... a biofilm pose a significant health risk due ... and biofilm-protected bacteria account for some 80 percent ... 50 to 1,000 times more resistant to antibiotics ... may have stumbled onto a magic bullet," said ...
(Date:8/26/2014)... Ill. University of Illinois engineers are bringing ... The researchers developed a new continuous glucose monitoring ... and the wavelength shift is so precise that ... it for automatic insulin dosing - something ... strips. , "There are significant limitations to current ...
(Date:8/26/2014)... at the University of Illinois at Urbana-Champaign have ... paving the way for power-on-a-chip applications. , ... scale that amplify light and produce ultra-narrowband spectral ... electrical and computer engineering (ECE) at Illinois. "These ... power on a chip containing both electronic and ...
Breaking Biology News(10 mins):Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2
... The efficacy of preimplantation genetic screening (PGS) has been ... over the past few years. None of the trials,carried ... or not. Now the European Society of Human,Reproduction and ... try to find out if a novel,method of doing ...
... what their football heroes can do with a football, the ... in excellent physical condition undoubtedly helps, few people actually believe ... into a Ronaldo. Now, scientists from the University of Queensland ... Dr. Robbie Wilson will talk about the details of this ...
... that the anti-malarial drug quinine can block a cell,s ... a discovery that may explain many of the adverse ... suggest that dietary tryptophan supplements could be a simple ... important drug. Quinine is a very commonly used ...
Cached Biology News:ESHRE launches international study of polar body screening 2What makes a great footballer? 2Tryptophan deficiency may underlie quinine side effects 2
ImageQuant 400, 1 EA. Category: ImageQuant CCD Imagers....
ImageQuant 100 UV, 1 EA. Category: ImageQuant CCD Imagers....
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Recombinant Rat PTX2/SAP...
Biology Products: